News

The acquisition – which will see MSD pay $107 for each American Depository Share (ADS) in UK-headquartered Verona – is the ...
MSD in the Philippines has earned Bronze in the “Community Impact and Engagement” category at the inaugural Corporate Social ...
Kentucky officials sought to sanction Advance Ready Mix Concrete before reaching a settlement earlier this year, documents show. The company allegedly provided about 16 tons of concrete for a bridge ...
The results of a phase 2 trial of MSD’s ROR1 inhibitor zilovertamab vedotin (zilo-V) back up the company's decision to push the antibody-drug conjugate (ADC) into a phase 3 programme.
MSD in the Philippines has earned Bronze in the “Community Impact and Engagement” category at the inaugural Corporate Social ...
Zilovertamab vedotin, an antibody drug conjugate (ADC) developed by Merck & Co (MSD) to treat diffuse large B-cell lymphoma (DLBCL), has demonstrated promise in a Phase II/III study, as the company ...
COPENHAGEN - Evaxion Biotech A/S (NASDAQ: EVAX), a clinical-stage TechBio company, has entered into an option and license agreement with pharmaceutical giant MSD, known as Merck & Co., Inc. in the U.S ...
A mentoring program is provided at three levels to coach each participant in career and leadership development ...